XGN
Exagen Inc
Price:  
3.56 
USD
Volume:  
47,757.00
United States | Health Care Providers & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

XGN WACC - Weighted Average Cost of Capital

The WACC of Exagen Inc (XGN) is 8.1%.

The Cost of Equity of Exagen Inc (XGN) is 8.50%.
The Cost of Debt of Exagen Inc (XGN) is 6.90%.

Range Selected
Cost of equity 6.10% - 10.90% 8.50%
Tax rate 0.30% - 0.50% 0.40%
Cost of debt 6.80% - 7.00% 6.90%
WACC 6.3% - 9.9% 8.1%
WACC

XGN WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.49 1.08
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.10% 10.90%
Tax rate 0.30% 0.50%
Debt/Equity ratio 0.32 0.32
Cost of debt 6.80% 7.00%
After-tax WACC 6.3% 9.9%
Selected WACC 8.1%